These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17057754)

  • 1. The twentieth century struggle to decipher insulin signalling.
    Cohen P
    Nat Rev Mol Cell Biol; 2006 Nov; 7(11):867-73. PubMed ID: 17057754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staying in SHIP shape.
    Decker SJ; Saltiel AR
    Nat Med; 2005 Feb; 11(2):123-4. PubMed ID: 15692594
    [No Abstract]   [Full Text] [Related]  

  • 3. SHIPing news: a new way to keep your weight down.
    Birnbaum MJ
    Cell Metab; 2005 Feb; 1(2):90-2. PubMed ID: 16054050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restraining PI3K: mTOR signalling goes back to the membrane.
    Harrington LS; Findlay GM; Lamb RF
    Trends Biochem Sci; 2005 Jan; 30(1):35-42. PubMed ID: 15653324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.
    Backers K; Blero D; Paternotte N; Zhang J; Erneux C
    Adv Enzyme Regul; 2003; 43():15-28. PubMed ID: 12791379
    [No Abstract]   [Full Text] [Related]  

  • 6. A thematic series on kinases and phosphatases that regulate lipid signaling.
    Prescott SM
    J Biol Chem; 1999 Mar; 274(13):8345-6. PubMed ID: 10085059
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid phosphatases as drug discovery targets for type 2 diabetes.
    Lazar DF; Saltiel AR
    Nat Rev Drug Discov; 2006 Apr; 5(4):333-42. PubMed ID: 16582877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin signalling and the regulation of glucose and lipid metabolism.
    Saltiel AR; Kahn CR
    Nature; 2001 Dec; 414(6865):799-806. PubMed ID: 11742412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular signalling mechanisms regulating glucose transport in insulin-sensitive tissues (review).
    Litherland GJ; Hajduch E; Hundal HS
    Mol Membr Biol; 2001; 18(3):195-204. PubMed ID: 11681786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.
    Suwa A; Yamamoto T; Sawada A; Minoura K; Hosogai N; Tahara A; Kurama T; Shimokawa T; Aramori I
    Br J Pharmacol; 2009 Oct; 158(3):879-87. PubMed ID: 19694723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHIP2: an emerging target for the treatment of type 2 diabetes mellitus.
    Baumgartener JW
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):291-8. PubMed ID: 14683460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pi 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes.
    Jiang G; Zhang BB
    Front Biosci; 2002 Apr; 7():d903-7. PubMed ID: 11897556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling.
    Vinciguerra M; Foti M
    Arch Physiol Biochem; 2006 Apr; 112(2):89-104. PubMed ID: 16931451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the mode-of-action of Cassia auriculata via in silico and in vivo studies towards validating it as a long term therapy for type II diabetes.
    Mohd Fauzi F; John CM; Karunanidhi A; Mussa HY; Ramasamy R; Adam A; Bender A
    J Ethnopharmacol; 2017 Feb; 197():61-72. PubMed ID: 27452659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives on the mechanism of insulin action.
    Czech MP
    Recent Prog Horm Res; 1984; 40():347-77. PubMed ID: 6207566
    [No Abstract]   [Full Text] [Related]  

  • 16. Phosphoinositide signaling disorders in human diseases.
    Pendaries C; Tronchère H; Plantavid M; Payrastre B
    FEBS Lett; 2003 Jul; 546(1):25-31. PubMed ID: 12829232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation.
    Carricaburu V; Lamia KA; Lo E; Favereaux L; Payrastre B; Cantley LC; Rameh LE
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9867-72. PubMed ID: 12897244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic challenges of kinase and phosphatase inhibition and use in anti-diabetic strategy.
    Bridges AJ
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):343-5. PubMed ID: 15787602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular process of glucose uptake and glycogen storage due to hamamelitannin via insulin signalling cascade in glucose metabolism.
    Issac PK; Guru A; Chandrakumar SS; Lite C; Saraswathi NT; Arasu MV; Al-Dhabi NA; Arshad A; Arockiaraj J
    Mol Biol Rep; 2020 Sep; 47(9):6727-6740. PubMed ID: 32809102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle.
    Ryder JW; Chibalin AV; Zierath JR
    Acta Physiol Scand; 2001 Mar; 171(3):249-57. PubMed ID: 11412137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.